Biblio Discovery — Demo Discovery Service

47 hasil untuk "Marc Ferrante"

Menampilkan 1–20 · 1,33 detik · RSS

  1. Artikel Jurnal

    New biologics and small molecules in inflammatory bowel disease: an update

    João Sabino; Bram Verstockt; Séverine Vermeire dkk.

    Therapeutic Advances in Gastroenterology, Vol. 12 · 2019 · Inggris · DOAJ Scopus

    Inflammatory bowel disease (IBD) is a spectrum of immune-mediated inflammatory disorders with a complex multifactorial pathogenesis, where different pathways may predominate in different individuals. This complexity will most likely require a panoply of drugs targeting different pathways if one…

  2. Artikel Jurnal

    Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?

    Ala I. Sharara; Maher Malaeb; Matthias Lenfant dkk.

    Inflammatory Intestinal Diseases, Pp 1-6 (2021) · 2021 · Inggris · DOAJ Scopus

    Background: Endoscopic remission is an increasingly recognized important therapeutic endpoint in the management of patients with UC. Summary: The Mayo Endoscopic Score (MES) remains the most common endoscopic index recommended in guidelines and widely used in clinical trials and in clinical…

  3. Artikel Jurnal

    Schwannoma of the cervical esophagus

    Marc Ferrante; Arfa Khan; Cathy Fan dkk.

    Rare Tumors, Vol. 6 No. 2 · 2014 · Inggris · DOAJ Scopus

    Esophageal schwannoma is a rare tumor first described in 1967 by Chaterlin and Fissore. These tumors are most commonly found incidentally or from diagnostic work up of dysphagia or dyspnea. This entity cannot be diagnosed on clinical or radiographic basis alone. Histology demonstrates palisading…

  4. Artikel Jurnal

    Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways

    Marileen M. Prins; Bram Verstockt; Marc Ferrante dkk.

    Frontiers in Immunology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    The expression of Triggering Receptor Expressed on Myeloid cells (TREM)-1 has been described as a predictive marker for anti-Tumor Necrosis Factor (TNF)-α monoclonal antibody (mAb) therapy responsiveness in patients with inflammatory bowel disease (IBD). Here we investigated expression of TREM-1…

  5. Artikel Jurnal

    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?

    Wannee Kantasiripitak; Ruth Van Daele; Matthias Gijsen dkk.

    Frontiers in Pharmacology, Vol. 11 · 2020 · Inggris · DOAJ Scopus

    Model-informed precision dosing (MIPD) software tools are used to optimize dosage regimens in individual patients, aiming to achieve drug exposure targets associated with desirable clinical outcomes. Over the last few decades, numerous MIPD software tools have been developed. However, they have…

  6. Artikel Jurnal

    Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials

    Isabelle Cleynen; Loes Linsen; Sare Verstockt dkk.

    Frontiers in Medicine, Vol. 6 · 2019 · Inggris · DOAJ Scopus

    Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory condition affecting mainly the gastro-intestinal tract with two main entities: Crohn's disease (CD) and ulcerative colitis (UC). Although the exact mechanisms underlying the initial development of IBD are not fully understood, it…

  7. Artikel Jurnal

    The Intraoperative Use of a Portable Cone-Beam Computed Tomography System for the Diagnosis of Intraperitoneal Bladder Perforation

    Ankur Choksi; Benjamin Press; Cayce Nawaf dkk.

    Case Reports in Urology, Vol. 2021 · 2021 · Inggris · DOAJ

    Background. Intraoperative imaging for endourologic procedures is generally limited to single-plane fluoroscopic X-ray. The O-arm™ is a mobile cone-bean CT scanner that may have applications in urologic surgeries. Case Presentation. We present a case of an 85-year-old male with radiation cystitis…

  8. Artikel Jurnal Teks lengkap

    Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: a analysis of the phase 2b/3 SELECTION study

    Masayuki Saruta; Silvio Danese; Yoshie Takatori dkk.

    Intestinal Research, Vol. 24 No. 2 · 2026 · Inggris · DOAJ Scopus

    Background/Aims Filgotinib is an oral, once-daily, Janus kinase 1 preferential inhibitor approved for the treatment of ulcerative colitis (UC). This study aimed to assess symptomatic response with filgotinib 200 mg (FIL200) according to disease severity using baseline partial Mayo Clinic Score…

  9. Artikel Jurnal

    Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD

    Séverine Vermeire; Marc Ferrante; Padhmanand Sudhakar dkk.

    BMJ Open Gastroenterology, Vol. 10 No. 1 · 2023 · Inggris · DOAJ Scopus

    Objective To infer potential mechanisms driving disease subtypes among patients with inflammatory bowel disease (IBD), we profiled the transcriptome of purified circulating monocytes and CD4 T-cells.Design RNA extracted from purified monocytes and CD4 T-cells derived from the peripheral blood of…

  10. Artikel Jurnal Teks lengkap

    Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis

    Ruben Faelens; Zhigang Wang; Thomas Bouillon dkk.

    Pharmaceutics, Vol. 13 No. 10 · 2021 · Inggris · DOAJ Scopus

    Model-informed precision dosing (MIPD) may be a solution to therapeutic failure of infliximab for patients with ulcerative colitis (UC), as underexposure could be avoided, and the probability of endoscopic improvement (pEI; Mayo endoscopic subscore ≤ 1) could be optimized. To investigate in silico…

  11. Artikel Jurnal

    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

    Padhmanand Sudhakar; Tahila Andrighetti; Sare Verstockt dkk.

    iScience, Vol. 25 No. 5 · 2022 · Inggris · DOAJ Scopus

    Summary: Inflammatory responses of the intestinal epithelial barrier in patients with Crohn’s disease (CD), a chronic inflammatory bowel disease (IBD), are associated with gut microbial alterations. At a community level, there is scarce mechanistic evidence on the effects of gut microbial…

  12. Artikel Jurnal

    Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study

    Roni Weisshof; Stephan R. Vavricka; Lieven Pouillon dkk.

    BMC Gastroenterology, Vol. 23 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Vedolizumab (VDZ), a gut-selective anti-lymphocyte trafficking integrin antibody, is effective in treating patients with moderately to severely active Crohn’s disease (CD). In this study, we examined the real-world effectiveness and safety of induction therapy using VDZ alone or…

  13. Artikel Jurnal

    Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in Belgium

    Liselotte Fierens; Frank E. Rademakers; Peter Bossuyt dkk.

    BMC Health Services Research, Vol. 26 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Introduction Quality indicators assess and can improve care. Previous efforts used different methods to identify quality indicators for inflammatory bowel disease (IBD) care in Belgium. This study aimed to critically evaluate these efforts and establish a validated, multi-stakeholder…

  14. Artikel Jurnal

    Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease

    Bram Verstockt; Clémentine Perrier; Gert De Hertogh dkk.

    Frontiers in Immunology, Vol. 9 · 2018 · Inggris · DOAJ Scopus

    Background: Mucosal IL-13 Receptor alpha 2 (IL13RA2) mRNA expression is one of the best predictive markers for primary non-responsiveness to infliximab therapy in patients with inflammatory bowel disease (IBD). The objective of this study was to understand how IL-13Rα2, a negative regulator of…

  15. Artikel Jurnal

    Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment

    Elise Schoefs; Séverine Vermeire; Marc Ferrante dkk.

    Frontiers in Medicine, Vol. 11 · 2024 · Inggris · DOAJ Scopus

    BackgroundAs the therapeutic landscape for inflammatory bowel disease (IBD) continues to expand, a need exists to understand how patients perceive and value different attributes associated with their disease as well as with current and emerging treatments. These insights can inform the development…

  16. Artikel Jurnal Teks lengkap

    Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis

    Ho-Su Lee; Maaike Vancamelbeke; Sare Verstockt dkk.

    Cells, Vol. 9 No. 8 · 2020 · Inggris · DOAJ Scopus

    Ulcerative colitis is a chronic inflammatory disease confined to the colon. Although the etiopathogenesis remains unknown, small bowel dysfunctions like histological and permeability alterations have been described in ulcerative colitis. We evaluated the molecular gene signature in the non-inflamed…

  17. Artikel Jurnal

    Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium

    Brecht Creyns; Inge Jacobs; Bram Verstockt dkk.

    Frontiers in Immunology, Vol. 11 · 2020 · Inggris · DOAJ Scopus

    Patients with Crohn disease (CD) and ulcerative colitis (UC) suffer from chronic relapsing intestinal inflammation. While many studies focused on adaptive immunity, less is known about the role of innate immune cells in these diseases. Innate lymphoid cells (ILCs) are recently identified cells with…

  18. Artikel Jurnal

    SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study

    Jeroen Geldof; Marie Truyens; João Sabino dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    BackgroundThe risks and impact of COVID19 disease and vaccination in patients with Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID patients and particularly patients receiving immunosuppressive treatment were excluded from the original, registrational phase-3…

  19. Artikel Jurnal

    Development and validation of the FR-QoL-29-Dutch (Flemish) Questionnaire and assessment of clinical factors associated with food-related quality of life in a Belgian inflammatory bowel disease population: a cross-sectional study

    Séverine Vermeire; Kevin Whelan; Marc Ferrante dkk.

    BMJ Open Gastroenterology, Vol. 12 No. 1 · 2025 · Inggris · DOAJ Scopus

    Objective Food-related quality of life (FR-QoL) is the psychosocial impact of food, nutrition, eating and drinking on QoL and can be profoundly affected by inflammatory bowel disease (IBD). We aimed to translate and validate the FR-QoL-29 Questionnaire in a Belgian IBD population and investigate…

  20. Artikel Jurnal

    Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells

    Brecht Creyns; Jonathan Cremer; Gert De Hertogh dkk.

    Immunity, Inflammation and Disease, Vol. 8 No. 3 · 2020 · Inggris · DOAJ Scopus

    Abstract Introduction Insight in the pathogenesis of intestinal fibrosis is an unmet medical need in inflammatory bowel diseases. Studies in murine models and human organ fibrosis point to a potential role of innate lymphoid cells (ILC) in chronic intestinal inflammation and fibrosis. Materials and…